• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC
Click for more information
2.37% $1.65

RACE ONCOLOGY LTD

Market Cap $281.2M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a... Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Corporate Spotlight

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight arrow Created with Sketch.

WEBINAR REPLAY: RACE ONCOLOGY

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAC
Ann: Date of AGM & Closing Date for Director Nominations 		07/10/24 5 1.5K
07/10/24 Last post  IndexInvestor Comments Created with Sketch.  5  Views Created with Sketch.  1.5K 
RAC
General Comments / Chat
196 197 198
07/10/24 11K 4.1M
07/10/24 Last post  IndexInvestor Comments Created with Sketch.  11K  Views Created with Sketch.  4.1M 
RAC
Industry news
38 39 40
07/10/24 2.3K 795K
07/10/24 Last post  Wasabi193 Comments Created with Sketch.  2.3K  Views Created with Sketch.  795K 
RAC
RAC - Charts & Price Action
375 376 377
07/10/24 22K 7.9M
07/10/24 Last post  PlayMoney76 Comments Created with Sketch.  22K  Views Created with Sketch.  7.9M 
RAC
Ann: Application for quotation of securities - RAC 		03/10/24 0 546
03/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  546 
RAC
Ann: Notification of cessation of securities - RAC 		02/10/24 2 1.0K
02/10/24 Last post  ASX News Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
RAC
Pillar 1 - FTO (new thread)
49 50 51
01/10/24 3.0K 1.0M
01/10/24 Last post  IndexInvestor Comments Created with Sketch.  3.0K  Views Created with Sketch.  1.0M 
RAC
Race Oncology $3 Milestone Cycling Gear
3 4 5
01/10/24 251 78K
01/10/24 Last post  australiasydney Comments Created with Sketch.  251  Views Created with Sketch.  78K 
RAC
RAC media coverage
37 38 39
30/09/24 2.2K 778K
30/09/24 Last post  KingBuzzo Comments Created with Sketch.  2.2K  Views Created with Sketch.  778K 
RAC
Cardioprotection thread
14 15 16
30/09/24 906 275K
30/09/24 Last post  HeyLine Comments Created with Sketch.  906  Views Created with Sketch.  275K 
RAC
CPACS: Research, Results, Market Comparisons, and Valuations
4 5 6
29/09/24 307 95K
29/09/24 Last post  Mason14 Comments Created with Sketch.  307  Views Created with Sketch.  95K 
RAC
Chat GPT Q&A
2 3 4
29/09/24 219 81K
29/09/24 Last post  NTinvest Comments Created with Sketch.  219  Views Created with Sketch.  81K 
RAC
RAC - Cash Analysis 		29/09/24 14 5.0K
29/09/24 Last post  cas33VFL Comments Created with Sketch.  14  Views Created with Sketch.  5.0K 
RAC
CEO of Race Oncology posting on a public internet forum
2 3 4
28/09/24 198 56K
28/09/24 Last post  LaughingBull Comments Created with Sketch.  198  Views Created with Sketch.  56K 
RAC
Ann: E&P Conference Presentation 		26/09/24 5 2.0K
26/09/24 Last post  hotcongo Comments Created with Sketch.  5  Views Created with Sketch.  2.0K 
RAC
Ann: Application for quotation of securities - RAC 		26/09/24 0 475
26/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  475 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Date of AGM & Closing Date for Director Nominations
07 Oct 08:59
 
Application for quotation of securities - RAC
03 Oct 13:20
 
Notification of cessation of securities - RAC
02 Oct 08:24
 
Application for quotation of securities - RAC
26 Sep 11:07
 
E&P Conference Presentation
26 Sep 11:07
 
HealthInvest 2024 Investor Presentation
18 Sep 09:50
 
View More arrow Created with Sketch.

Featured News

NEWS Antler Copper Project hits major permitting milestone – air quality permit advances to final review
right-arrow Created with Sketch.
NEWS Second consecutive quarter of record revenue driven by strong sales growth in market-leading medical products!
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
NEWS Waroona Project financing strategy aims for non-dilutive funding solutions - discover how this approach will support its Stage One development
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Positive diamond results allow for scoping study update
right-arrow Created with Sketch.

(20min delay)
Last
$1.65 		Change
-0.040(2.37%) 		Mkt cap ! $281.2M
Open High Low Value Volume
$1.69 $1.69 $1.64 $50.53K 30.36K

Buyers (Bids)

No. Vol. Price($)
1 539 $1.65
 

Sellers (Offers)

Price($) Vol. No.
$1.69 731 1
View Market Depth
Last trade - 16.10pm 07/10/2024 (20 minute delay) ?
Last
$1.68 		  Change
-0.040 ( 0.59 %)
Open High Low Volume
$1.66 $1.69 $1.64 13233
Last updated 15.54pm 07/10/2024 ?
RAC (ASX) Chart

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest drug trial.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome Neuren has confirmed it's received "positive" FDA responses for its Phase III trial to treat children with Phelan-McDermid syndrome.
Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program Arika Resources Ltd has received commitments from investors in support of a Placement worth $3.2 million to support gold exploration in WA
Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03 Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats, suggesting it causes no genetic damage

Featured News

NEWS See what company has secured $98M, 8-year contract renewal with Mercy Health
right-arrow Created with Sketch.
NEWS Most viewed thread today: Rio Tinto confirms approach to Arcadium Lithium
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS Positive diamond results allow for scoping study update
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.